Loading quotes...
Forecast
There is no analyst data available for this company.
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 2.55m | - |
| Gross profit | -11.85m | - |
| Net profit | -30.46m | - |
| EBITDA | -17.09m | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €850.21m |
Number of shares | 602.34m |
52-week high/low | €4.63 - €0.86 |
| Dividends | No |
Beta | 1.84 |
P/E ratio | -5.83 |
PEG ratio | 0.01 |
P/B ratio | 8.07 |
P/S ratio | 196.19 |
Company profile
4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lung ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent 200, a small animal ventilator. The company was incorporated in 2012 and is based in Carlton, Australia.
| Name | 4DMEDICAL LTD. Aktie |
| CEO | Andreas Fouras |
| Headquarters | Carlton,
vic Australia |
| Website | |
| IPO | 07/08/2020 |
| Employees | 181 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
Australian Securities Exchange Ltd | 4DX.AX |
Pnk | FDMDF |